Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.

Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.

Item
http://www.wikidata.org/entity/Q46246952
Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysisHeparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKLBone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management.Targeting bone as a therapy for myeloma.Multiple myeloma--an update on diagnosis and treatment.A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment.The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.Emerging biological insights and novel treatment strategies in multiple myeloma.Perspectives in the treatment of multiple myeloma.The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases.Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease.Prospective study of signalling pathways in myeloma bone disease with regard to activity of the disease, extent of skeletal involvement and correlation to bone turnover markers.
P2860

Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.

Item
http://www.wikidata.org/entity/Q46246952
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Incorporation of the bone mark ...... symptomatic multiple myeloma.
@en
Incorporation of the bone mark ...... symptomatic multiple myeloma.
@nl
type
label
Incorporation of the bone mark ...... symptomatic multiple myeloma.
@en
Incorporation of the bone mark ...... symptomatic multiple myeloma.
@nl
prefLabel
Incorporation of the bone mark ...... symptomatic multiple myeloma.
@en
Incorporation of the bone mark ...... symptomatic multiple myeloma.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Incorporation of the bone mark ...... symptomatic multiple myeloma.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698